TRIJARDY XR Extended-release tablet Ref.[50504] Active ingredients: Empagliflozin Linagliptin Metformin

Source: FDA, National Drug Code (US)  Revision Year: 2022 

Product description

TRIJARDY XR tablets for oral use contain: empagliflozin, linagliptin, and metformin hydrochloride.

Empagliflozin

Empagliflozin is an inhibitor of the sodium-glucose co-transporter 2 (SGLT2).

The chemical name of empagliflozin is D-Glucitol,1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-, (1S).

The molecular formula is C23H27ClO7 and the molecular weight is 450.91.

The structural formula is:

Empagliflozin is a white to yellowish, non-hygroscopic powder. It is very slightly soluble in water, sparingly soluble in methanol, slightly soluble in ethanol and acetonitrile, soluble in 50% acetonitrile/water, and practically insoluble in toluene.

Linagliptin

Linagliptin is an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme.

The chemical name of linagliptin is 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]7(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-

The molecular formula is C25H28N8O2 and the molecular weight is 472.54.

The structural formula is:

Linagliptin is a white to yellowish, not or only slightly hygroscopic solid substance. It is very slightly soluble in water. Linagliptin is soluble in methanol, sparingly soluble in ethanol, very slightly soluble in isopropanol, and very slightly soluble in acetone.

Metformin hydrochloride

Metformin hydrochloride (N,N-dimethylimidodicarbonimidic diamide hydrochloride) is a biguanide. Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5∙HCl and a molecular weight of 165.63. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride is 6.68.

The structural formula is:

TRIJARDY XR

Each film coated tablet of TRIJARDY XR consists of an extended-release metformin hydrochloride core tablet that is coated with the immediate-release drug substances: empagliflozin and linagliptin.

TRIJARDY XR tablets for oral administration are available in four strengths containing:

  • 5 mg empagliflozin/2.5 mg linagliptin/1000 mg metformin hydrochloride extended-release
  • 10 mg empagliflozin/5 mg linagliptin/1000 mg metformin hydrochloride extended-release
  • 12.5 mg empagliflozin/2.5 mg linagliptin/1000 mg metformin hydrochloride extended-release
  • 25 mg empagliflozin/5 mg linagliptin/1000 mg metformin hydrochloride extended-release

Each film-coated tablet of TRIJARDY XR contains the following inactive ingredients: Tablet Core: polyethylene oxide, hypromellose, and magnesium stearate. Film Coatings and Printing Ink: hydroxypropyl cellulose, hypromellose, talc, titanium dioxide, arginine, polyethylene glycol, carnauba wax, purified water, shellac glaze, n-butyl alcohol, propylene glycol, ammonium hydroxide, isopropyl alcohol, ferrosoferric oxide and ferric oxide yellow (5 mg/2.5 mg/1000 mg and 25 mg/5 mg/1000 mg), ferric oxide yellow and ferric oxide red (10 mg/5 mg/1000 mg), and ferrosoferric oxide and ferric oxide red (12.5 mg/2.5 mg/1000 mg).

Dosage Forms and Strengths

TRIJARDY XR Tablets:

Empagliflozin Strength Linagliptin Strength Metformin HCl Extended-Release Strength Color/Shape Tablet Markings
5 mg 2.5 mg 1000 mg grey, oval-shaped, film-coated tablet Printed on one side in white ink with the BI logo and “395” on the top line and “5/2.5” on the bottom line
10 mg 5 mg 1000 mg tan, oval-shaped, film-coated tablet Printed on one side in white ink with the BI logo and “380” on the top line and “10/5” on the bottom line
12.5 mg 2.5 mg 1000 mg red, oval-shaped, film-coated tablet Printed on one side in white ink with the BI logo and “385” on the top line and “12.5/2.5” on the bottom line
25 mg 5 mg 1000 mg brown, oval-shaped, film-coated tablet Printed on one side in white ink with the BI logo and “390” on the top line and “25/5” on the bottom line
How Supplied

TRIJARDY XR tablets are available as follows:

Tablet Strength Color/Shape Tablet Markings Package Size NDC Number
5 mg Empagliflozin
2.5 mg Linagliptin
1000 mg Metformin HCl Extended-Release
grey, oval-shaped, film-coated tablet Printed on one side in white ink with the BI logo and “395” on the top line and “5/2.5” on the bottom line Bottles of 60
Bottles of 180
0597-0395-82
0597-0395-23
10 mg Empagliflozin
5 mg Linagliptin
1000 mg Metformin HCl Extended-Release
tan, oval-shaped, film-coated tablet Printed on one side in white ink with the BI logo and “380” on the top line and “10/5” on the bottom line Bottles of 30
Bottles of 90
0597-0380-13
0597-0380-68
12.5 mg Empagliflozin
2.5 mg Linagliptin
1000 mg Metformin HCl Extended-Release
red, oval-shaped, film-coated tablet Printed on one side in white ink with the BI logo and “385” on the top line and “12.5/2.5” on the bottom line Bottles of 60
Bottles of 180
0597-0385-77
0597-0385-86
25 mg Empagliflozin
5 mg Linagliptin
1000 mg Metformin HCl Extended-Release
brown, oval-shaped, film-coated tablet Printed on one side in white ink with the BI logo and “390” on the top line and “25/5” on the bottom line Bottles of 30
Bottles of 90
0597-0390-71
0597-0390-13

Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA

Marketed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA and Eli Lilly and Company, Indianapolis, IN 46285 USA

Licensed from: Boehringer Ingelheim International GmbH, Ingelheim, Germany.

Drugs

Drug Countries
TRIJARDY XR United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.